Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
Clinical trial NCT00302016 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT00302016
- Sponsor
- Novartis Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
- Start date
- 2006-01-01
- Primary completion
- 2008-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.